Real-time enrollment status for this her2-positive breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:07 PM UTC
| NCT Number | NCT05325632 |
| Recruiting Status | Recruiting |
| Condition | HER2-positive Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 53 participants |
| Active Locations | 1 sites in the US |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Last Updated on CT.gov | March 2, 2026 (Mar 2, 2026) |
As of July 13, 2026: Clinical trial NCT05325632 is currently recruiting participants. This clinical trial study for her2-positive breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by H. Lee Moffitt Cancer Center and Research Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05325632 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05325632 was last updated Mar 2, 2026 (March 2, 2026). HelloStudys verifies this status automatically.